In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA -- best known for being used in Covid-19 vaccines -- in the hopes of ...

Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...

A flu vaccine that harnesses the messenger RNA technology that ended the COVID-19 pandemic appears increasingly likely, ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...

The same mRNA technology used in COVID-19 vaccines may offer a powerful new way to prevent long-term muscle damage caused by ...

A joint Singaporean-Chinese research team has developed an Evans Blue-modified lipid nanoparticle platform that directs mRNA ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...